The Cooper Companies, Inc. $COO Stock: New Mexico Educational Retirement Board Boosts Position

New Mexico Educational Retirement Board grew its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 98.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,238 shares of the medical device company’s stock after purchasing an additional 9,538 shares during the period. New Mexico Educational Retirement Board’s holdings in Cooper Companies were worth $1,088,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of the business. Algert Global LLC purchased a new position in Cooper Companies during the second quarter worth about $7,655,000. Bank of America Corp DE purchased a new stake in shares of Cooper Companies in the 2nd quarter valued at approximately $144,125,000. BlackRock Inc. purchased a new stake in shares of Cooper Companies in the 2nd quarter valued at approximately $1,077,762,000. National Pension Service raised its stake in shares of Cooper Companies by 9,314.0% in the 2nd quarter. National Pension Service now owns 526,149 shares of the medical device company’s stock valued at $37,730,000 after acquiring an additional 520,560 shares during the period. Finally, Arizona State Retirement System boosted its position in shares of Cooper Companies by 108.2% during the 2nd quarter. Arizona State Retirement System now owns 110,873 shares of the medical device company’s stock worth $7,951,000 after purchasing an additional 57,621 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on COO shares. Stifel Nicolaus set a $70.00 target price on shares of Cooper Companies and gave the company a “buy” rating in a report on Thursday, September 10th. UBS Group decreased their price target on Cooper Companies from $75.00 to $66.00 and set a “neutral” rating on the stock in a research note on Thursday, September 10th. Wells Fargo & Company set a $61.00 price target on Cooper Companies and gave the stock an “equal weight” rating in a research report on Thursday, September 10th. Robert W. Baird set a $61.00 price objective on Cooper Companies and gave the company a “neutral” rating in a research note on Thursday, September 10th. Finally, Zacks Research downgraded Cooper Companies from a “hold” rating to a “strong sell” rating in a report on Friday, September 11th. Four investment analysts have rated the stock with a Buy rating, twelve have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $68.60.

Insider Activity at Cooper Companies

In other news, Director Paul Keel purchased 4,701 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The stock was bought at an average price of $53.18 per share, for a total transaction of $249,999.18. Following the completion of the purchase, the director directly owned 4,701 shares of the company’s stock, valued at $249,999.18. The trade was a ∞ increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Lawrence Kurzius purchased 10,000 shares of the stock in a transaction on Wednesday, September 16th. The shares were purchased at an average price of $54.93 per share, with a total value of $549,300.00. Following the acquisition, the director directly owned 31,099 shares in the company, valued at $1,708,268.07. This represents a 47.40% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have bought a total of 34,701 shares of company stock valued at $1,880,039 over the last 90 days. 2.08% of the stock is owned by corporate insiders.

Cooper Companies Price Performance

COO stock opened at $62.93 on Thursday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.22 and a quick ratio of 0.73. The firm has a market capitalization of $11.97 billion, a P/E ratio of 21.48, a P/E/G ratio of 2.50 and a beta of 0.83. The business’s 50-day moving average is $58.80 and its two-hundred day moving average is $68.33. The Cooper Companies, Inc. has a 1 year low of $51.01 and a 1 year high of $89.83.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. Cooper Companies had a return on equity of 10.90% and a net margin of 13.46%. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same period in the previous year, the company posted $0.49 earnings per share. The business’s revenue for the quarter was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. Analysts anticipate that The Cooper Companies, Inc. will post 4.53 earnings per share for the current fiscal year.

Cooper Companies announced that its Board of Directors has authorized a share buyback plan on Wednesday, September 9th that permits the company to buy back $3 billion in shares. This repurchase authorization permits the medical device company to repurchase up to 22.7% of its stock through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.

Cooper Companies Profile

CooperCompanies is a global medical device company focused on vision care and women’s health. It serves customers in markets around the world through two primary businesses: CooperVision and CooperSurgical. CooperVision develops and sells contact lenses, including products for daily wear, astigmatism, presbyopia and myopia management. Its offerings include lenses made from silicone hydrogel and other materials, as well as specialty lens options. CooperSurgical provides products and services for women’s health and fertility care.